explore -WSS

explore

author：fashion 2025-09-02 22:06:49 - browse：73213

Telehealth menopause treatment options displayed on cellphones emerging from a crack in the ground. -- health tech coverage from STAT — Molly Ferguson for STAT

At the turn of the century, nearly 18 million women in the United States were battling hot flashes, night sweats, and other symptoms of menopause with hormones. But in 2002, the therapy went into a free-fall when a landmark trial suggested treating menopause with estrogen and progesterone increased the risk of breast cancer and cardiovascular disease. The study was shut down early — and a year later, prescriptions had plummeted to nearly half what they had been in 2001.

More than two decades later, menopause experts have come to think about the results of the trial very differently. Newer research points to more benefits than risks for many healthy women under 60 treating menopause symptoms with hormone therapy. But many women who are good fits still aren’t getting treatment. “The pendulum has been slowly — too slowly — swinging back,” said OB-GYN Mike Green, chief medical officer of menopause telehealth company Winona.

Winona is part of a new generation of virtual-first health care companies aiming to give that pendulum a push. In the last five years, more than a dozen telehealth companies have started up to serve women in and approaching menopause, including with hormone therapy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Community Health Systems hospitals under DOJ investigation

explore

WSS

Smaller biotechs seek to piggyback on weight loss drug boom

Dario to buy mental health app maker Twill in cash and stock deal

6 phony surgeries that take placebo to the extreme

NIH study of ME/CFS points to clear biological hallmarks

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

leisure time

explore

Wikipedia

United colonoscopy coverage change 'may cost lives,' doctors say

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

In Memoriam: Notable people who died in 2023

With competition flaring, obesity drug hits goal in liver disease study

George Santos makes 1st court appearance after pleading not guilty to 13 counts

ADCs take center stage as promising cancer treatments

ChatGPT in medicine: STAT answers readers' burning questions

New documents shed light on MD Anderson Cancer Institute feud

New air purifier tech could be key to improving indoor air quality

A solution to the after

entertainment

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Study on Amgen’s bispecific immunotherapy produces positive data

STAT Readout Newsletter: Biotech news today

UnitedHealth, Optum discontinue NaviHealth name

The problems with dementia villages

With competition flaring, obesity drug hits goal in liver disease study

focus

explore

focus

explore